Press Releases BioSig Technologies, Inc.

Equities

BSGM

US09073N3008

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.37 ^USD	+5.38%		-2.84%	-71.16%

Apr. 16	BioSig Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 12	BioSig Technologies Inc. Issues Promissory Note to an Investor for $500,000	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioSig Technologies : Annual report pursuant to Section 13 and 15(d)	Apr. 16	PU
BioSig Engages Consulting Firm for Business Model Strategies	Apr. 04	AQ
BioSig Technologies : Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT	Apr. 02	PU
BioSig Technologies : Failure to Satisfy Listing Rule - Form 8-K	Mar. 18	PU
BioSig Announces Reduction of its Workforce	Feb. 20	AQ
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases	Feb. 06	AQ
BioSig Announces Reverse Stock Split	Jan. 31	GL
BioSig Announces Reverse Stock Split	Jan. 31	AQ
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy	Jan. 30	GL
BioSig Technologies : Corporate Summary	Dec. 18	PU
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024	Dec. 06	GL
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024	Dec. 06	AQ
BioSig Technologies : Corporate Summary	Nov. 28	PU
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	Nov. 13	GL
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	Nov. 09	GL
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	Nov. 09	AQ
BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VP	Nov. 07	GL
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care	Nov. 02	GL
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care	Nov. 02	AQ
BioSig Adds Five New Patent Awards to 100+ Total Patent Portfolio Covering Digital Signal Processing Technology and AI	Nov. 01	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases BioSig Technologies, Inc.

Equities

BSGM

US09073N3008

Press Releases

Filters